BioScrip Inc. (Nasdaq: BIOS) reported a loss for the third quarter and cut its current quarter and full year forecast. Shares of the home infusion services firm tumbled $1.25 to close at $1.36.
BioScrip reports loss, cuts outlook
November 08, 2016 at 17:05 PM EST
